Exclusion of candidate genes in a family with arterial tortuosity syndrome

被引:40
作者
Gardella, R
Zoppi, N
Assanelli, D
Muiesan, ML
Barlati, S
Colombi, M
机构
[1] Univ Brescia, Fac Med, Div Biol & Genet, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy
[2] Univ Brescia, Fac Med, Dept Med & Surg Sci, I-25123 Brescia, Italy
关键词
arterial tortuosity; connective tissue; Ehlers-Danlos syndrome; pulmonary stenosis; pulmonary hypertension; fibronectin; collagen genes;
D O I
10.1002/ajmg.a.20589
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Arterial tortuosity syndrome (ATS) is a rare hereditary disorder with variable clinical presentation including tortuosity and elongation of the major arteries, often associated with pulmonary artery stenosis, pulmonary hypertension, and skin and joint laxity, suggestive of a connective tissue disorder. ATS is transmitted in an autosomal recessive mode, but the causal gene is unknown. We report an Italian pedigree with three inbred families in which five patients show signs of ATS. In particular, four adult patients present arterial tortuosity and elongation of the main arteries. Two of these patients, with the most severe degree of arterial tortuosity, also show severe peripheral stenosis of the main pulmonary artery. The fifth young patient shows a severe pulmonary valve stenosis in the absence of arterial tortuosity. All patients show signs of Ehlers-Danlos syndrome (EDS): soft skin with abundant subcutaneous tissue and joint laxity, hernias, and disorganization of the extracellular matrix (ECM) of fibronectin (FN) and of actin microfilaments in cultured skin fibroblasts. Linkage analysis of the genes involved in EDS and other connective tissue disorders, excluded COL1A1, COL1A2, COL2A1, COL3A1, COL5A1, COL5A2, COL5A3, COL6A1, COL6A2, ADAMTS2, ELN, FN1, TNXA, and TAXB as candidate genes in the family under study, thus indicating that ATS is a distinct clinical and molecular entity. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 37 条
[1]  
Ades LC, 1996, AM J MED GENET, V66, P289, DOI 10.1002/(SICI)1096-8628(19961218)66:3<289::AID-AJMG11>3.3.CO
[2]  
2-M
[3]  
Al Fadley F, 2000, CARDIOL YOUNG, V10, P582
[4]   DYSPLASIA OF SYSTEMIC AND PULMONARY ARTERIAL SYSTEM WITH TORTUOSITY AND LENGTHENING OF ARTERIES - A NEW ENTITY DIAGNOSED DURING LIFE AND LEADING TO CORONARY DEATH IN EARLY CHILDHOOD [J].
BEUREN, AJ ;
HORT, W ;
KALBFLEISCH, H ;
MULLER, H ;
STOERMER, J .
CIRCULATION, 1969, 39 (01) :109-+
[5]   COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of α1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II [J].
Bouma, P ;
Cabral, WA ;
Cole, WG ;
Marini, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :13356-13364
[6]   Extracellular matrix in vascular morphogenesis and disease: structure versus signal [J].
Brooke, BS ;
Karnik, SK ;
Li, DY .
TRENDS IN CELL BIOLOGY, 2003, 13 (01) :51-56
[7]  
Chi D. D., 1992, Human Molecular Genetics, V1, P135, DOI 10.1093/hmg/1.2.135
[8]   Human Ehlers-Danlos syndrome type VIIC and bovine dermatosparaxis are caused by mutations in the procollagen IN-proteinase gene [J].
Colige, A ;
Sieron, AL ;
Li, SW ;
Schwarze, U ;
Petty, E ;
Wertelecki, W ;
Wilcox, W ;
Krakow, D ;
Cohn, DH ;
Reardon, W ;
Byers, PH ;
Lapière, CM ;
Prockop, DJ ;
Nusgens, BV .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) :308-317
[9]   Identification of a polymorphic CA repeat in the COL6A2 gene on human chromosome 21q22.3 [J].
Comeglio, P ;
Saitta, B ;
Pepe, G ;
Chu, ML .
HUMAN HEREDITY, 1996, 46 (04) :239-240
[10]   EHLERS-DANLOS SYNDROME TYPE-IV - CLINICAL AND MOLECULAR ASPECTS AND GUIDELINES FOR DIAGNOSIS AND MANAGEMENT [J].
DEPAEPE, A .
DERMATOLOGY, 1994, 189 :21-25